drugset / Trial / NCT06048536
Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch
RandomizedParallel-groupOpen-labelTreatment
Summary
A single-center, randomized, open-label, parallel-group, multi-arm, phase II clinical trial in healthy women aged 18 to 35 years who have a documented ovulatory cycle prior to randomization.
Timeline
- Start
- 2023-12-22
- Primary completion
- 2024-01-18
- Completion
- 2024-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | norelgestromin | Unknown | 2.43 mg | Other |
| Subject | norelgestromin | Unknown | 3.64 mg | Other |
| Subject | norelgestromin | Unknown | 4.86 mg | Other |
Indications
No indication recorded.